The Science Circuit

  Image credit:   https://openai.com/index/dall-e/     Cancer treatments called   PD-1 inhibitors   have been a real game-changer, helping the body's own immune system to fight off tumours. These drugs work by taking the 'brakes' off the immune system, allowing it to attack cancer cells more effectively. However, sometimes this revved-up immune response can go a bit too far and start attacking healthy parts of the body, leading to what are known as   immune-related adverse events (irAEs) . One of the irAEs that doctors are seeing more and more is   inflammatory arthritis (IA) , where the joints become painful and swollen. While this can look a bit like another common condition called   rheumatoid arthritis (RA) , there are clues that the two might be different under the surface. For instance, PD-1-induced IA (or   PD-1-IA   for short) often doesn't show the same tell-tale signs in blood tests as RA, suggesting different things are g...

    Image credit:   https://openai.com/index/dall-e/ Systemic lupus erythematosus(SLE) , or lupus, is a tricky illness that affects people in different ways. Some might have mild symptoms, like skin rashes or joint pain, while others experience much more serious, life-threatening problems. It's a disease where the body's immune system, which usually fights off infections, attacks its own tissues and organs. Scientists have been working hard to understand what goes wrong in lupus and how to help people who have it. One of the things that makes lupus complicated is that many different things can contribute to it, including a person's genes and how their immune system works. It's also known that a protein called interferon (IFN) is often activated in lupus patients. While blocking interferon has been tried as a treatment, it doesn't work for everyone. This has led researchers to look deeper into the immune system to figure out other players involved in the disease. ...